Pharmaceuticals

AMRI Realigns Global Operations to Enhance Continuous Supply Chain for Customers

ALBANY, N.Y., Feb. 13, 2015 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced that it has implemented several changes to further optimize global business operations in order to enhance continuity from early development through to commercial supply and accelerate the company's global growth obje...

2015-02-13 05:00 2852

BioFire Defense, a bioMerieux Company, Receives Prestigious Frost & Sullivan's 2014 Global New Product Innovation Award for its FilmArray(R) Ebola Test

SALT LAKE CITY, Feb. 10, 2015 /PRNewswire/ -- BioFire Defense, LLC is proud to announce that it is the recipient of the Frost & Sullivan's 2014 Global New Product Innovation Award for its FilmArray® Ebola test. The New Product Innovation Award is given to companies that display strong overall per...

2015-02-10 15:00 1590

U.S. FDA Grants Priority Review to YONDELIS® NDA for Advanced Soft-tissue Sarcoma

MADRID, Feb. 4, 2015 /PRNewswire/ -- PharmaMar announces that the U.S. Food and Drug Administration (FDA) has granted priority review to YONDELIS® (trabectedin) New Drug Application (NDA) for the treatment of patients with advanced soft tissue sarcoma (STS), including liposarcoma and leiomyosarco...

2015-02-04 09:30 2213

MicroConstants China In-licenses Global Rights of AA98 Antibody Drug Candidates from Institute of Biophysics, Chinese Academy of Sciences

BEIJING, Jan. 30, 2015 /PRNewswire/ -- MicroConstants China Inc., announced today that it has signed a licensing agreement to gain the global rights for the development of AA98 antibody drug candidates for the treatment of various cancers, multiple sclerosis (MS), and age related macular degenera...

2015-01-30 00:52 2440

American Heart Association continues global expansion of lifesaving work

DALLAS, Jan. 27, 2015 /PRNewswire/ -- Cardiovascular disease knows no borders, and currently accounts for more than 17 million deaths per year, a figure expected to reach approximately 23 million per year by 2030. That's why the American Heart Association (AHA) is committed to building healthier ...

2015-01-27 23:00 1152

European Hantavirus Diagnostics Market Tops US Market as a Result of Higher Disease Prevalence

MOUNTAIN VIEW, Calif., Jan. 27, 2015 /PRNewswire/ -- The European Hantavirus diagnostics market is growing at a compound annual growth rate (CAGR) of 5.8 percent, outperforming the U.S. market, which registered 3.7 percent. The European market is more robust primarily due to Hantavirus' high prev...

2015-01-27 20:45 1866

Pfanstiehl Launches New cGMP-produced, Parenteral Grade Maltose for Pharmaceutical Formulations

CHICAGO, Jan. 26, 2015 /PRNewswire/ -- Pfanstiehl has announced the launch of a new high purity, low endotoxin, Maltose (USP/NF, EP, JP), manufactured in the US under strict cGMP, ICH Q7 compliant conditions.  "Maltose is a multifunctional disaccharide used to stabilize protein therapeutics, i...

2015-01-26 21:52 1297

Malaysia well positioned to grow in medical tourism, medical devices and private healthcare services, says Frost & Sullivan

KUALA LUMPUR, Malaysia, Jan. 26, 2015 /PRNewswire/ -- By 2025, total healthcare expenditure inMalaysia could exceed USD20 billion. In the next five years (2015 to 2020), it is expected to grow at a compound annual growth rate (CAGR) of 11%. While Government spending will focus on development of p...

2015-01-26 14:58 1317

European Medicines Agency Accepts Samsung Bioepis' Enbrel(R) Biosimilar Candidate, SB4, for Regulatory Review

INCHEON, South Korea, Jan. 21, 2015 /PRNewswire/ -- Samsung Bioepis Co., Ltd., today announced that the Marketing Authorization Application (MAA) for its Enbrel (etanercept) biosimilar candidate, SB4, has been validated and accepted for review by European Medicines Agency (EMA). The acceptance of...

2015-01-21 22:00 2767

Mundipharma Announces Plans to Distribute Medifoam in China

SINGAPORE, Jan. 15, 2015 /PRNewswire/ -- Mundipharma today announced its planned distribution ofMedifoam® in China starting early 2015, marking a key milestone in the company's plan to rapidly expand the innovative moist wound dressing product's reach inEast Asia and South East Asia. Medifoam® wa...

2015-01-15 10:00 2356

Polymer Chameleons Find New Applications as Research Activities Rise

MOUNTAIN VIEW, Calif., Jan. 13, 2015 /PRNewswire/ -- Polymer chameleons are poised for rapid adoption and commercialization across industries due to their unique attributes and benefits. Despite several challenges, research activities and partnerships between the research community and the indust...

2015-01-13 21:00 2037

Analysts Predict a Big Year for Healthcare in 2015

MOUNTAIN VIEW, Calif., Jan. 13, 2015 /PRNewswire/ -- WHEN: 10:00 a.m. EST on Tuesday, Jan. 27, 2015 LOCATION: Online, with Free Registration (Email Jennifer.Carson@Frost.com ) MODERATOR: Frost & Sullivan Partner and Senior Vice President of Healthcare...

2015-01-13 20:45 1435

PharmaMar Will Start a Phase III Study of PM1183 in Combination With Doxorubicin in Relapsed SCLC

MADRID, Jan. 13, 2015 /PRNewswire/ -- * The unparalleled results obtained in the Phase Ib study support the start of a head-to-head study in relapsed small-cell lung cancer (SCLC) patients that will compare the combination as second line therapy against topotecan, the only drug approved in th...

2015-01-13 09:30 1891

A World First at the Montreal Heart Institute - Discovery of a personalized therapy for cardiovascular disease

MONTREAL, Jan. 13, 2015 /PRNewswire/ -- Researchers at the Montreal Heart Institute announced today results showing that patients with cardiovascular disease and the appropriate genetic background benefit greatly from the new medication dalcetrapib, with a reduction of 39% in combined clinical ou...

2015-01-13 09:08 2247

AMRI to Acquire Aptuit Drug Product Development and Aseptic Clinical Manufacturing Businesses

ALBANY, New York, Jan. 9, 2015 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced that it has acquired the outstanding equity interests of Aptuit's Glasgow, UK business and has entered into a definitive agreement to acquire Aptuit's SSCI/West Lafayette, Ind. business for total consideration of $6...

2015-01-09 20:00 2168

DiaCarta, Inc Closes $8 Million Series A Round for Development and Commercialization of Precision Molecular Diagnostics

HAYWARD, California and SHANGHAI, Jan. 9, 2015 /PRNewswire/ -- DiaCarta, Inc., a privately-held biotechnology company raised$8 million in Series A financing from BVCF (BioVeda China Fund). Proceeds from Series A financing will be used to expand the product portfolio and support global commerciali...

2015-01-09 18:50 3021

DKSH to provide Market Expansion Services for Nestle's Materna in China

SHANGHAI, Jan. 9, 2015 /PRNewswire/ -- DKSH Business Unit Healthcare, the leading Market Expansion Services provider for healthcare companies seeking to grow their business inAsia, will provide full service distribution and commercial services for Nestle's Materna products including marketing a...

2015-01-09 14:00 3502

New class of antibiotics - bioengineered to deter the development of antibiotic resistance

MONTREAL, Jan. 9, 2015 /PRNewswire/ -- SinSa Labs today announced the signing of a License agreement with Singapore Health Services and ETPL, A*STAR's technology transfer arm, regarding a technology developed at the Singapore Eye Research Institute (SERI) and Bioinformatics Institute (BII), A*STA...

2015-01-09 04:29 2191

Turkish Life Sciences Industry Fuelled by Favourable Investment Climate and Healthcare Reforms

LONDON, Jan. 8, 2015 /PRNewswire/ -- Big pharmaceutical companies and foreign investors are flocking toTurkey to capitalise on its encouraging economic policies. The establishment of technology development zones thatexempt pharmaceutical entrepreneurs and academics from income taxes until 2023 ha...

2015-01-08 20:43 1323

LEO Pharma Announces US Regulatory Submission of the First Aerosol Foam for Psoriasis

BALLERUP, Denmark, Jan. 6, 2015 /PRNewswire/ -- LEO Pharma announced it has submitted a New Drug Application to the US Food and Drug Administration (FDA) for calcipotriene/betamethasone dipropionate aerosol foam 0,005%/0,064% for the treatment of psoriasis vulgaris. The novel aerosol foam formul...

2015-01-06 13:01 1554
1 ... 36373839404142 ... 46